{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:25:23Z","timestamp":1757543123881,"version":"3.38.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/jcp.0b013e3181faf53e","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T09:06:35Z","timestamp":1288343195000},"page":"720-725","source":"Crossref","is-referenced-by-count":20,"title":["Levetiracetam for the Treatment of Alcohol Withdrawal Syndrome"],"prefix":"10.1097","volume":"30","author":[{"given":"Christoph","family":"Richter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Hinzpeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Folkhard","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Kienast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich W.","family":"Preuss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Plenge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210128","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jama.1997.03550020076042","article-title":"Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal.","volume":"278","author":"Mayo-Smith","year":"1997","journal-title":"JAMA"},{"key":"R2-14-20210128","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/BF02602395","article-title":"Alcohol withdrawal: a nationwide survey of inpatient treatment practices.","volume":"10","author":"Saitz","year":"1995","journal-title":"J Gen Intern Med"},{"key":"R3-14-20210128","first-page":"313","article-title":"Toxicological interactions between alcohol and benzodiazepines.","volume":"17","author":"Tanaka","year":"2004","journal-title":"Chudoku Kenkyu"},{"key":"R4-14-20210128","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s001340051094","article-title":"Prolonged sedation requiring mechanical ventilation and continuous flumazenil infusion after routine doses of clorazepam for alcohol withdrawal syndrome.","volume":"25","author":"Guglielminotti","year":"1999","journal-title":"Intensive Care Med"},{"key":"R5-14-20210128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/j.1875-9114.1996.tb02915.x","article-title":"Benzodiazepines for alcohol withdrawal in the elderly and in patients with liver disease.","volume":"16","author":"Peppers","year":"1996","journal-title":"Pharmacotherapy"},{"key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1360-0443.2003.00631.x","article-title":"A postmarketing study of relative abuse liability of hypnotic sedative drugs.","volume":"99","author":"Jaffe","year":"2004","journal-title":"Addiction"},{"issue":"suppl 5","key":"R7-14-20210128","first-page":"7","article-title":"Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.","volume":"65","author":"Chouinard","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R8-14-20210128","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00000542-199005000-00024","article-title":"Benzodiazepines and human memory: a review.","volume":"72","author":"Ghoneim","year":"1990","journal-title":"Anesthesiology"},{"key":"R9-14-20210128","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-2006-931479","article-title":"Efficacy and safety of outpatient alcohol detoxification with a combination of tiapride\/carbamazepine: additional evidence.","volume":"39","author":"Soyka","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"R10-14-20210128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1300\/J069v21n02_05","article-title":"Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention.","volume":"21","author":"Longo","year":"2002","journal-title":"J Addict Dis"},{"key":"R11-14-20210128","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00406-006-0644-8","article-title":"Treatment of alcohol withdrawal syndrome with a combination of tiapride\/carbamazepine: results of a pooled analysis in 540 patients.","volume":"256","author":"Soyka","year":"2006","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R12-14-20210128","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-0028-1109214","article-title":"Anticonvulsants in the treatment of alcoholism.","volume":"77","author":"Bonnet","year":"2009","journal-title":"Fortschr Neurol Psychiatr"},{"key":"R13-14-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.133.1.1","article-title":"Kindling as a model for alcohol withdrawal syndromes.","volume":"133","author":"Ballenger","year":"1978","journal-title":"Br J Psychiatry"},{"key":"R14-14-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0149-7634(03)00030-7","article-title":"Alcohol and withdrawal: from animal research to clinical issues.","volume":"27","author":"De Witte","year":"2003","journal-title":"Neurosci Biobehav Rev"},{"key":"R15-14-20210128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0920-1211(98)00018-7","article-title":"Effects of lamotrigine and conventional antiepileptic drugs on amygdala- and hippocampal-kindled seizures in rats.","volume":"31","author":"Otsuki","year":"1998","journal-title":"Epilepsy Res"},{"key":"R16-14-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-2999(97)01347-2","article-title":"BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy.","volume":"339","author":"Morimoto","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"suppl 1","key":"R17-14-20210128","first-page":"S9","article-title":"Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: focus on levetiracetam.","volume":"5","author":"Klitgaard","year":"2003","journal-title":"Epileptic Disord"},{"key":"R18-14-20210128","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-3565(24)37251-9","article-title":"Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy.","volume":"284","author":"Loscher","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"R19-14-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0920-1211(02)00254-1","article-title":"Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model.","volume":"53","author":"Stratton","year":"2003","journal-title":"Epilepsy Res"},{"key":"R20-14-20210128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1528-1157.1994.tb02930.x","article-title":"Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review.","volume":"35","author":"Van Amelsvoort","year":"1994","journal-title":"Epilepsia"},{"key":"R22-14-20210128","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1592\/phco.21.20.1549.34480","article-title":"Pancreatitis associated with valproic acid: a review of the literature.","volume":"21","author":"Chapman","year":"2001","journal-title":"Pharmacotherapy"},{"key":"R23-14-20210128","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1097\/00004714-200002001-00001","article-title":"Comprehensive review of the psychiatric uses of valproate.","volume":"20","author":"Davis","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"R24-14-20210128","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1345\/aph.17332","article-title":"A mechanistic approach to antiepileptic drug interactions.","volume":"32","author":"Anderson","year":"1998","journal-title":"Ann Pharmacother"},{"key":"R25-14-20210128","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000252941.50833.4a","article-title":"Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.","volume":"68","author":"Brodie","year":"2007","journal-title":"Neurology"},{"key":"R26-14-20210128","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0920-1211(01)00296-0","article-title":"A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.","volume":"47","author":"French","year":"2001","journal-title":"Epilepsy Res"},{"key":"R27-14-20210128","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1212\/01.WNL.0000133214.78602.B3","article-title":"A prospective analysis of the outcome of levetiracetam in clinical practice.","volume":"63","author":"Nicolson","year":"2004","journal-title":"Neurology"},{"key":"R28-14-20210128","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1059-1311(03)00139-0","article-title":"Levetiracetam treatment of idiopathic generalised epilepsy.","volume":"12","author":"Krauss","year":"2003","journal-title":"Seizure"},{"key":"R29-14-20210128","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0041-1345(03)00361-0","article-title":"Levetiracetam monotherapy for liver transplant patients with seizures.","volume":"35","author":"Chabolla","year":"2003","journal-title":"Transplant Proc"},{"key":"R30-14-20210128","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.0013-9580.2004.00204.x","article-title":"Levetiracetam in focal epilepsy and hepatic porphyria: a case report.","volume":"45","author":"Paul","year":"2004","journal-title":"Epilepsia"},{"key":"R31-14-20210128","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0090-9556(24)15285-3","article-title":"In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent.","volume":"27","author":"Nicolas","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"R33-14-20210128","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/01.jcp.0000219926.49799.89","article-title":"Levetiracetam for the treatment of alcohol withdrawal syndrome: an open-label pilot trial.","volume":"26","author":"Krebs","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"R34-14-20210128","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/oxfordjournals.alcalc.a008326","article-title":"A new rating scale for the assessment of the alcohol-withdrawal syndrome (AWS scale).","volume":"32","author":"Wetterling","year":"1997","journal-title":"Alcohol Alcohol"},{"key":"R35-14-20210128","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","article-title":"Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment For Alcohol Scale (CIWA-Ar).","volume":"84","author":"Sullivan","year":"1989","journal-title":"Br J Addict"},{"key":"R37-14-20210128","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance.","volume":"33","author":"Endicott","year":"1976","journal-title":"Arch Gen Psychiatry"},{"key":"R38-14-20210128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R43-14-20210128","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1517\/14740338.3.5.415","article-title":"Levetiracetam safety profiles and tolerability in epilepsy patients.","volume":"3","author":"Briggs","year":"2004","journal-title":"Expert Opin Drug Saf"},{"key":"R44-14-20210128","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1358\/dot.2007.43.11.1136902","article-title":"Levetiracetam.","volume":"43","author":"Carreno","year":"2007","journal-title":"Drugs Today (Barc)"},{"key":"R45-14-20210128","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/01.nrl.0000340792.61037.40","article-title":"Antiepileptic drug interactions.","volume":"14","author":"Diaz","year":"2008","journal-title":"Neurologist"},{"key":"R46-14-20210128","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/02791072.2005.10399814","article-title":"A retrospective chart review comparing tiagabine and benzodiazepines for the treatment of alcohol withdrawal.","volume":"37","author":"Myrick","year":"2005","journal-title":"J Psychoactive Drugs"},{"key":"R47-14-20210128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/oxfordjournals.alcalc.a008107","article-title":"The irreversible gamma-aminobutyrate transaminase inhibitor vigabatrin in the treatment of the alcohol withdrawal syndrome.","volume":"31","author":"Stuppaeck","year":"1996","journal-title":"Alcohol Alcohol"},{"key":"R48-14-20210128","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/13556210500224015","article-title":"Oxcarbazepine versus carbamazepine in the treatment of alcohol withdrawal.","volume":"10","author":"Schik","year":"2005","journal-title":"Addict Biol"},{"key":"R49-14-20210128","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1530-0277.2007.00419.x","article-title":"Oxcarbazepine-efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study.","volume":"31","author":"Koethe","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"R50-14-20210128","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0741-8329(89)90022-0","article-title":"Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid.","volume":"6","author":"Hillbom","year":"1989","journal-title":"Alcohol"},{"key":"R51-14-20210128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1081\/ADA-100100597","article-title":"Divalproex in the treatment of alcohol withdrawal.","volume":"26","author":"Myrick","year":"2000","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R52-14-20210128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/00048678009159381","article-title":"Sodium valproate in the treatment of the alcohol withdrawal syndrome.","volume":"14","author":"Lambie","year":"1980","journal-title":"Aust N Z J Psychiatry"},{"key":"R53-14-20210128","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1530-0277.2009.00986.x","article-title":"A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.","volume":"33","author":"Myrick","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"R54-14-20210128","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.","volume":"361","author":"Johnson","year":"2003","journal-title":"Lancet"},{"key":"R55-14-20210128","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/JCP.0b013e3181aba6a4","article-title":"Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms.","volume":"29","author":"Anton","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"R56-14-20210128","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/alcalc\/agp085","article-title":"An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol.","volume":"45","author":"Bonnet","year":"2010","journal-title":"Alcohol Alcohol"},{"key":"R57-14-20210128","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pnpbp.2006.11.006","article-title":"Gabapentin's acute effect on mood profile-a controlled study on patients with alcohol withdrawal.","volume":"31","author":"Bonnet","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R58-14-20210128","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/01.CCM.0000256841.28351.80","article-title":"A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens.","volume":"35","author":"Gold","year":"2007","journal-title":"Crit Care Med"},{"key":"R59-14-20210128","first-page":"305","article-title":"The utility of diazepam loading in the treatment of alcohol withdrawal among psychiatric inpatients.","volume":"31","author":"Salloum","year":"1995","journal-title":"Psychopharmacol Bull"},{"key":"R60-14-20210128","first-page":"170","article-title":"Loading dose diazepam therapy for alcohol withdrawal state.","volume":"98","author":"Manikant","year":"1993","journal-title":"Indian J Med Res"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-201012000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T11:18:10Z","timestamp":1740655090000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201012000-00014"}},"subtitle":["A Multicenter, Prospective, Randomized, Placebo-Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181faf53e","relation":{},"ISSN":["0271-0749"],"issn-type":[{"type":"print","value":"0271-0749"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}